Sorafenib Tosylate/Comekibart | Interleukin Related interleukin-related.com

Product Name :
Sorafenib Tosylate/Comekibart

Search keywords :
Sorafenib (Tosylate)

drugId :
null

Target Vo:
Vascular endothelial growth factor receptor 1

Target Vo Short Name :
VEGFR1

Moa_Name:
Vascular endothelial growth factor receptor 3 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Metagone Biotech Inc

Active Company_Name :
Metagone Biotech Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SOX10 Antibody
Caspase 1 Antibody
beta Tubulin Antibody (HRP) (YA865): beta Tubulin Antibody (HRP) (YA865) is an approximately 50-55 kDa, mouse-derived, anti-beta Tubulin (HRP) (YA865) monoclonal antibody. beta Tubulin Antibody (HRP) (YA865) can be used for: WB expriments in human, mouse, monkey, hamster, rat background with HRP labeling.

Author: Interleukin Related

Related Posts